相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Knockdown of zinc finger protein 267 suppresses diffuse large B-cell lymphoma progression, metastasis, and cancer stem cell properties
Hua Yang et al.
BIOENGINEERED (2022)
Beyond PARP1: The Potential of Other Members of the Poly (ADP-Ribose) Polymerase Family in DNA Repair and Cancer Therapeutics
Iain A. Richard et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2022)
Medicinal Chemistry Perspective on Targeting Mono-ADP-Ribosylating PARPs with Small Molecules
Maria Giulia Nizi et al.
JOURNAL OF MEDICINAL CHEMISTRY (2022)
The Expression Profile of miRNA in Glioma and the Role of miR-339-5p in Glioma
Jie Lin et al.
BIOMED RESEARCH INTERNATIONAL (2022)
Copy Number Variation of Circulating Tumor DNA (ctDNA) Detected Using NIPT in Neoadjuvant Chemotherapy-Treated Ovarian Cancer Patients
Mina Sharbatoghli et al.
FRONTIERS IN GENETICS (2022)
Accumulation of copy number alterations and clinical progression across advanced prostate cancer
Emily Grist et al.
GENOME MEDICINE (2022)
Genetic factors associated with prostate cancer conversion from active surveillance to treatment
Yu Jiang et al.
HUMAN GENETICS AND GENOMICS ADVANCES (2022)
The Expression Profile of miRNA in Glioma and the Role of miR-339-5p in Glioma
Jie Lin et al.
BIOMED RESEARCH INTERNATIONAL (2022)
Molecular Pathology of Prostate Cancer
Ibrahim Kulac et al.
Surgical Pathology Clinics (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
SPP1 Promotes Enzalutamide Resistance and Epithelial-Mesenchymal-Transition Activation in Castration-Resistant Prostate Cancer via PI3K/AKT and ERK1/2 Pathways
Xiaocong Pang et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2021)
Somatic driver mutation prevalence in 1844 prostate cancers identifies ZNRF3 loss as a predictor of metastatic relapse
Michael Fraser et al.
NATURE COMMUNICATIONS (2021)
MARTs and MARylation in the Cytosol: Biological Functions, Mechanisms of Action, and Therapeutic Potential
Sridevi Challa et al.
CELLS (2021)
Reduced NCOR2 expression accelerates androgen deprivation therapy failure in prostate cancer
Mark D. Long et al.
CELL REPORTS (2021)
Repurposing hyperpolarization-activated cyclic nucleotide-gated channels as a novel therapy for breast cancer
Ka-Chun Mok et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2021)
Analysis of the EGFR Amplification and CDKN2A Deletion Regulated Transcriptomic Signatures Reveals the Prognostic Significance of SPATS2L in Patients With Glioma
Haiwei Wang et al.
FRONTIERS IN ONCOLOGY (2021)
Oncogenic gene fusions in nonneoplastic precursors as evidence that bacterial infection can initiate prostate cancer
Eva Shrestha et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
CDKN1B Deletions are Associated with Metastasis in African American Men with Clinically Localized, Surgically Treated Prostate Cancer
Farzana A. Faisal et al.
CLINICAL CANCER RESEARCH (2020)
ETV4 promotes late development of prostatic intraepithelial neoplasia and cell proliferation through direct and p53-mediated downregulation of p21
Irene Cosi et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)
Quality of Life in Patients With Low-Risk Prostate Cancer Treated With Hypofractionated vs Conventional Radiotherapy A Phase 3 Randomized Clinical Trial
Deborah W. Bruner et al.
JAMA ONCOLOGY (2019)
Quality of life after external beam radiotherapy for localized prostate cancer: Comparison with other modalities
Katsumasa Nakamura et al.
INTERNATIONAL JOURNAL OF UROLOGY (2019)
Genomic correlates of clinical outcome in advanced prostate cancer
Wassim Abida et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Epigenetically Upregulated MicroRNA-602 Is Involved in a Negative Feedback Loop with FOXK2 in Esophageal Squamous Cell Carcinoma
Meiyue Liu et al.
MOLECULAR THERAPY (2019)
TP53 structural variants in metastatic prostatic carcinoma
Deepika Sirohi et al.
PLOS ONE (2019)
Compound Genomic Alterations of TP53, PTEN, and RB1 Tumor Suppressors in Localized and Metastatic Prostate Cancer
Anis A. Humid et al.
EUROPEAN UROLOGY (2019)
Tumor mutational load predicts survival after immunotherapy across multiple cancer types
Robert M. Samstein et al.
NATURE GENETICS (2019)
Disruption of ETV6 leads to TWIST1-dependent progression and resistance to epidermal growth factor receptor tyrosine kinase inhibitors in prostate cancer
Yuan-Chin Tsai et al.
MOLECULAR CANCER (2018)
Identification of Pik3ca Mutation as a Genetic Driver of Prostate Cancer That Cooperates with Pten Loss to Accelerate Progression and Castration-Resistant Growth
Helen B. Pearson et al.
CANCER DISCOVERY (2018)
Prognostic Values of CCNE1 Amplification and Overexpression in Cancer Patients: A Systematic Review and Meta-analysis
Haiyue Zhao et al.
JOURNAL OF CANCER (2018)
Genomic profiling of metastatic gastric adenocarcinoma
Kazuto Harada et al.
CANCER RESEARCH (2018)
Serum level of co-expressed hub miRNAs as diagnostic and prognostic biomarkers for pancreatic ductal adenocarcinoma
Qiang Su et al.
JOURNAL OF CANCER (2018)
Genomic hallmarks of localized, non-indolent prostate cancer
Michael Fraser et al.
NATURE (2017)
BCL2 genotypes and prostate cancer survival
Wilfried Renner et al.
STRAHLENTHERAPIE UND ONKOLOGIE (2017)
Polymorphisms of ESR1, UGT1A1, HCN1, MAP3K1 and CYP2B6 are associated with the prognosis of hormone receptor-positive early breast cancer
Sung-Hsin Kuo et al.
ONCOTARGET (2017)
Appraising the relevance of DNA copy number loss and gain in prostate cancer using whole genome DNA sequence data
Niedzica Camacho et al.
PLOS GENETICS (2017)
Hyperpolarization-activated cyclic nucleotide-gated gene signatures and poor clinical outcome of cancer patient
Nam Nhut Phan et al.
TRANSLATIONAL CANCER RESEARCH (2017)
Overexpressed HSF1 cancer signature genes cluster in human chromosome 8q
Christopher Q. Zhang et al.
HUMAN GENOMICS (2017)
Novel circulating microRNAs expression profile in colon cancer: a pilot study
Ya-nan Wang et al.
EUROPEAN JOURNAL OF MEDICAL RESEARCH (2017)
NCOA2 is a candidate target gene of 8q gain associated with clinically aggressive prostate cancer
Maria P. Silva et al.
GENES CHROMOSOMES & CANCER (2016)
Implications of Genetic and Epigenetic Alterations of CDKN2A (p16INK4a) in Cancer
Ran Zhao et al.
EBIOMEDICINE (2016)
PLZF, a Tumor Suppressor Genetically Lost in Metastatic Castration-Resistant Prostate Cancer, Is a Mediator of Resistance to Androgen Deprivation Therapy
Chen-Lin Hsieh et al.
CANCER RESEARCH (2015)
Coordinate Loss of MAP3K7 and CHD1 Promotes Aggressive Prostate Cancer
Lindsey Ulkus Rodrigues et al.
CANCER RESEARCH (2015)
Integrative Clinical Genomics of Advanced Prostate Cancer
Dan Robinson et al.
CELL (2015)
Regulation of the expression of zinc finger protein genes by microRNAs enriched within acute lymphoblastic leukemia-derived microvesicles
L. Lu et al.
GENETICS AND MOLECULAR RESEARCH (2015)
A multicenter study shows PTEN deletion is strongly associated with seminal vesicle involvement and extracapsular extension in localized prostate cancer
Dean A. Troyer et al.
PROSTATE (2015)
Integration of copy number and transcriptomics provides risk stratification in prostate cancer: A discovery and validation cohort study
H. Ross-Adams et al.
EBIOMEDICINE (2015)
MED12 overexpression is a frequent event in castration-resistant prostate cancer
Zaki Shaikhibrahim et al.
ENDOCRINE-RELATED CANCER (2014)
Androgen deprivation-induced NCoA2 promotes metastatic and castration-resistant prostate cancer
Jun Qin et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Identification of intrinsic subtype-specific prognostic microRNAs in primary glioblastoma
Rui Li et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2014)
TMPRSS2-ERG Expression Predicts Prostate Cancer Survival and Associates with Stromal Biomarkers
Christina Hagglof et al.
PLOS ONE (2014)
Copy number alteration burden predicts prostate cancer relapse
Haley Hieronymus et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Recurrent copy number alterations in prostate cancer: an in silico meta-analysis of publicly available genomic data
Julia L. Williams et al.
CANCER GENETICS (2014)
Prognostic Histopathological and Molecular Markers on Prostate Cancer Needle-Biopsies: A Review
A. Marije Hoogland et al.
BIOMED RESEARCH INTERNATIONAL (2014)
Genetic markers associated with early cancer-specific mortality following prostatectomy
Wennuan Liu et al.
CANCER (2013)
ETV4 promotes metastasis in response to activation of PI3-kinase and Ras signaling in a mouse model of advanced prostate cancer
Alvaro Aytes et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
A Molecular Signature Predictive of Indolent Prostate Cancer
Shazia Irshad et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Genomic Deletion of PTEN Is Associated with Tumor Progression and Early PSA Recurrence in ERG Fusion-Positive and Fusion-Negative Prostate Cancer
Antje Krohn et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
Copy number alterations of c-MYC and PTEN are prognostic factors for relapse after prostate cancer radiotherapy
Gaetano Zafarana et al.
CANCER (2012)
Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer
Christopher E. Barbieri et al.
NATURE GENETICS (2012)
MICRORNA-453 REGULATES IL-1β-INDUCED SONIC HEDGEHOG (SHH) GENE EXPRESSION IN OSTEOARTHRITIS
N. Akhtar et al.
OSTEOARTHRITIS AND CARTILAGE (2012)
Overexpression of ETV4 is oncogenic in prostate cells through promotion of both cell proliferation and epithelial to mesenchymal transition
A. Pellecchia et al.
ONCOGENESIS (2012)
Prognostic value of promoter hypermethylation of Retinoic Acid Receptor Beta (RARB) and CDKN2 (p16/MTS1) in prostate cancer
A. Ameri et al.
CHINESE JOURNAL OF CANCER RESEARCH (2011)
Zinc finger protein 267 is up-regulated in hepatocellular carcinoma and promotes tumor cell proliferation and migration
Bernd Schnabl et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2011)
Increased gene copy number of ERG on chromosome 21 but not TMPRSS2-ERG fusion predicts outcome in prostatic adenocarcinomas
Antoun Toubaji et al.
MODERN PATHOLOGY (2011)
MicroRNA-602 regulating tumor suppressive gene RASSF1A is overexpressed in hepatitis B virus-infected liver and hepatocellular carcinoma
Lian Yang et al.
CANCER BIOLOGY & THERAPY (2010)
Integrative Genomic Profiling of Human Prostate Cancer
Barry S. Taylor et al.
CANCER CELL (2010)
The landscape of somatic copy-number alteration across human cancers
Rameen Beroukhim et al.
NATURE (2010)
Deregulation of FOXO3A during prostate cancer progression
Sanjeev Shukla et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2009)
TMPRSS2-ERG gene fusion status in minute (minimal) prostatic adenocarcinoma
Roula Albadine et al.
MODERN PATHOLOGY (2009)
ETS family transcription factors collaborate with alternative signaling pathways to induce carcinoma from adult murine prostate cells
Yang Zong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Recurrent gene fusions in prostate cancer
Chandan Kumar-Sinha et al.
NATURE REVIEWS CANCER (2008)
FISH analysis of 107 prostate cancers shows that PTEN genomic deletion is associated with poor clinical outcome
M. Yoshimoto et al.
BRITISH JOURNAL OF CANCER (2007)
TMPRSS2-ERG fusion prostate cancer:: An early molecular event associated with invasion
Sven Perner et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2007)
Relationship of NKX3.1 and MYC gene copy number ratio and DNA hypomethylation to prostate carcinoma stage
R Kindich et al.
EUROPEAN UROLOGY (2006)
BCL-2 in prostate cancer: A minireview
SD Catz et al.
APOPTOSIS (2003)
分享论文
